Skip to main content
. 2020 Sep 29;2020:8885338. doi: 10.1155/2020/8885338

Table 1.

Structures of tested non-antimicrobial drugs screened for antibacterial effects on S. aureus and P. aeruginosa, MIC, and % cell viability.

Drug Organism MIC (μg/ml) % cell viability
Probenecid S. aureus 42.8
graphic file with name ijmicro2020-8885338.tab1.i001.jpg P. aeruginosa 56.9
Amodiaquine S. aureus 33
graphic file with name ijmicro2020-8885338.tab1.i002.jpg P. aeruginosa 43.2
2-Amino-5-chlorobenzaxazole S. aureus 34.7
graphic file with name ijmicro2020-8885338.tab1.i003.jpg P. aeruginosa 46
Quercetin S. aureus 40
graphic file with name ijmicro2020-8885338.tab1.i004.jpg P. aeruginosa 65.9
Ibuprofen S. aureus 70.6
graphic file with name ijmicro2020-8885338.tab1.i005.jpg P. aeruginosa 59.3
Epicatechin
graphic file with name ijmicro2020-8885338.tab1.i006.jpg S. aureus 7.1
P. aeruginosa 49
Ellargic acid S. aureus 100 4.9
graphic file with name ijmicro2020-8885338.tab1.i007.jpg P. aeruginosa 36.8
Curcumin S. aureus 100
−2.98
graphic file with name ijmicro2020-8885338.tab1.i008.jpg P. aeruginosa 50 −16.6
N–N Diacryloylpiperazine S. aureus 58
graphic file with name ijmicro2020-8885338.tab1.i009.jpg P. aeruginosa 54
Quinine S. aureus 13.1
graphic file with name ijmicro2020-8885338.tab1.i010.jpg P. aeruginosa 40.3
Ciprofloxacin S. aureus 0.25 −0.8
graphic file with name ijmicro2020-8885338.tab1.i011.jpg P. aeruginosa 0.5 −1.1

“–” indicates no MIC.